Filing Details

Accession Number:
0001209191-17-029346
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-02 18:01:07
Reporting Period:
2017-05-01
Filing Date:
2017-05-02
Accepted Time:
2017-05-02 18:01:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
879169 Incyte Corp INCY Services-Commercial Physical & Biological Research (8731) 943136539
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1615842 P Barry Flannelly 1801 Augustine Cut-Off
Wilmington DE 19803
Evp & General Manager Us No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-05-01 2,064 $48.44 17,949 No 4 M Direct
Common Stock Disposition 2017-05-01 803 $124.61 17,146 No 4 S Direct
Common Stock Disposition 2017-05-01 4,493 $124.75 12,653 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Incentive Stock Option (right to buy) Disposition 2017-05-01 2,064 $0.00 2,064 $48.44
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,720 2021-08-10 No 4 M Direct
Footnotes
  1. Reporting person undertakes to provide upon request by Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within range indicated.
  2. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by reporting person.
  3. Represents weighted average sale price. Actual sale prices ranged from $123.97 - $125.38.
  4. Represents weighted average sale price. Actual sale prices ranged from $123.92 - $125.47.
  5. Includes an aggregate of 11,187 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.
  6. Beginning August 11, 2014, options become exercisable in 25 installments, with the first 33.33% vesting after one year and the remainder vesting monthly over two years